Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
Cryotherapeutics from Ans, company number BE0713882584, closed financial year 2025 with a result of € -2.3 million after tax. For that financial year Cryotherapeutics recorded a gross margin of € -29,208 and equity of € 21.1 million. Compared with financial year 2024, the result moved from € -2 million to € -2.3 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.
€ 21.1 million
▼ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2.3 million
▼ 15 % more loss than in 2024
Profit after tax over the fiscal year.
€ 2.8 million
▼ 12% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -11 million.
People and assets in 2025
10.7
▲ 0.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.1 million
▲ 10% vs 2024
€ 103,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 38,893
▲ 85% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 424,327
▼ 20% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 181,240
▼ 22% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -217,944 | € 188,462 | € 23,850 | € -29,208 | ▼ € 53,058 |
| Profit after taxes | € -1,694,220 | € -1,815,782 | € -1,971,359 | € -2,258,299 | ▼ € 286,939 |
| Equity | € 19,794,989 | € 17,979,208 | € 23,345,446 | € 21,087,147 | ▼ 10% |
| Total debts | € 1,567,012 | € 2,069,321 | € 1,415,487 | € 693,714 | ▼ 51% |
| Cash | € 3,163,924 | € 1,406,551 | € 3,180,816 | € 2,784,170 | ▼ 12% |
| Retained profit | € -4,986,676 | € -6,802,458 | € -8,773,817 | € -11,032,116 | ▼ € 2.3 million |
| Bank debt | € 300,000 | € 300,000 | € 0 | € 0 | |
| Balance sheet total | € 21,362,002 | € 20,048,529 | € 24,760,933 | € 21,780,861 | ▼ 12% |
| Employees (FTE) | 5.4 | 7.9 | 10 | 10.7 | ▲ 0.7 |
Key figures of Cryotherapeutics, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Cryotherapeutics?
What happened at Cryotherapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Yiannakis YIANNI stepped down as director. NBB
- NOSHAQ Partners SCRL stepped down as director. NBB
- NRW BANK stepped down as director. NBB
- Chen Yen-Fu stepped down as director. NBB
- Peppermint Venture Partners GMBH stepped down as director. NBB
- Christine RAINER stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2.3 million. Source: NBB ↗
- Yiannakis YIANNI became a director. NBB
In short
From € 1.7 million loss in 2022 to € 2.3 million loss in 2025.
On average € 2,400 of value added per employee in 2024.
A new publication or filing at Cryotherapeutics? We notify you, reason included.
Follow CryotherapeuticsDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 100% of Cryotherapeutics GmbH itself.
Directors
According to the 2025 annual accounts
Yiannakis YIANNI
Managing director
since 2025 · until 2028
Director · represented by Eric BRANDT
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE, SOGECOM, VITAVERDE.BIO, HAEMERS Technologies, SPACEBEL, NOSHAQ VENTURE +169 more
since 2025 · until 2028
NRW BANK
Director · represented by Florian STINAUER
since 2025 · until 2028
Chen Yen-Fu
Director
since 2025 · until 2028
Peppermint Venture Partners GMBH
Director · represented by Joachim RAUTTER
since 2025 · until 2028
Christine RAINER
Director
since 2025 · until 2028
Establishments
Establishment units
Physical locations of this company
Avenue Alfred Deponthière 46 box 21
4431 Ans
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
CLOUDFLARESPECTRUM Cloudflare, Inc., US
DNS
OVH DNS
Domain
Domain
cryotherapeutics.com
Registered
2005-03-01
Registrar
OVH sas
Expires
2027-03-01
Website info
Features
Security
Details
- Company number
- 0713.882.584
- VAT number
- BE 0713.882.584
- Registered office
- Avenue Alfred Deponthière 46 bus 21, 4431 Ans
- Names & denominations
- Cryotherapeutics
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 26 November 2018
- Peppol
- Active · Active since 16 Sept 2025
- Contact
- cryotherapeutics.com
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Vervaardiging van overige farmaceutische producten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Detailhandel in farmaceutische producten